Cargando…
A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478320/ https://www.ncbi.nlm.nih.gov/pubmed/36803102 http://dx.doi.org/10.1177/00099228231154364 |
_version_ | 1785101323207704576 |
---|---|
author | Zu’bi, Fadi Pokarowski, Martha Al-Kutbi, Rusul Science, Michelle Vallipuram, Janaki O’Kelly, Fardod Chua, Michael Friedman, Jeremy Koyle, Martin |
author_facet | Zu’bi, Fadi Pokarowski, Martha Al-Kutbi, Rusul Science, Michelle Vallipuram, Janaki O’Kelly, Fardod Chua, Michael Friedman, Jeremy Koyle, Martin |
author_sort | Zu’bi, Fadi |
collection | PubMed |
description | Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration (long [>3 days] vs short [≤3 days]) and treatment failure via a retrospective review of infants with confirmed UTIs receiving IV antibiotics at a tertiary referral center. A total of 403 infants were included; 39% were treated with ampicillin and cefotaxime, and 34% with ampicillin and gentamycin or tobramycin. The median IV antibiotic duration was 5 (interquartile range: 3-10) days, and 5% of patients experienced treatment failure. The treatment failure rate was similar in both short- and long-course IV antibiotic groups (P > .05), and there was no significant association between treatment duration and failure. We conclude that treatment failure for infants hospitalized with UTI is uncommon and not associated with IV antibiotic duration. |
format | Online Article Text |
id | pubmed-10478320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104783202023-09-06 A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age Zu’bi, Fadi Pokarowski, Martha Al-Kutbi, Rusul Science, Michelle Vallipuram, Janaki O’Kelly, Fardod Chua, Michael Friedman, Jeremy Koyle, Martin Clin Pediatr (Phila) Articles Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration (long [>3 days] vs short [≤3 days]) and treatment failure via a retrospective review of infants with confirmed UTIs receiving IV antibiotics at a tertiary referral center. A total of 403 infants were included; 39% were treated with ampicillin and cefotaxime, and 34% with ampicillin and gentamycin or tobramycin. The median IV antibiotic duration was 5 (interquartile range: 3-10) days, and 5% of patients experienced treatment failure. The treatment failure rate was similar in both short- and long-course IV antibiotic groups (P > .05), and there was no significant association between treatment duration and failure. We conclude that treatment failure for infants hospitalized with UTI is uncommon and not associated with IV antibiotic duration. SAGE Publications 2023-02-21 2023-10 /pmc/articles/PMC10478320/ /pubmed/36803102 http://dx.doi.org/10.1177/00099228231154364 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Zu’bi, Fadi Pokarowski, Martha Al-Kutbi, Rusul Science, Michelle Vallipuram, Janaki O’Kelly, Fardod Chua, Michael Friedman, Jeremy Koyle, Martin A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title | A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title_full | A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title_fullStr | A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title_full_unstemmed | A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title_short | A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age |
title_sort | comparison of short versus long course intravenous antibiotics when treating urinary tract infection in infants <60 days of age |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478320/ https://www.ncbi.nlm.nih.gov/pubmed/36803102 http://dx.doi.org/10.1177/00099228231154364 |
work_keys_str_mv | AT zubifadi acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT pokarowskimartha acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT alkutbirusul acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT sciencemichelle acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT vallipuramjanaki acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT okellyfardod acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT chuamichael acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT friedmanjeremy acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT koylemartin acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT zubifadi comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT pokarowskimartha comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT alkutbirusul comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT sciencemichelle comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT vallipuramjanaki comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT okellyfardod comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT chuamichael comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT friedmanjeremy comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage AT koylemartin comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage |